Cincinnati Startups and VC Firms in 2026: 84.51°, CincyTech, Medpace
Cincinnati venture map in 2026 — Kroger’s 84.51° data science, Assurex Health’s GeneSight exit, Medpace (CRO), plus CincyTech and QCA Ventures.
Healthtech Venture Capital & Digital Health Funding
Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Healthtech VC Themes
- Digital health: Telehealth, care navigation, and patient engagement
- AI in healthcare: Clinical decision support, documentation, and operations
- Biopharma adjacencies: Drug discovery tools and life-sciences infrastructure
- Payer & provider tech: Revenue cycle, benefits, and workforce solutions
Browse healthtech venture capital articles below.
Related Articles (62 articles)
-
-
Birmingham AL Startups and VC Firms in 2026: Healthcare Density, Real Companies, Real Capital
Birmingham, Alabama’s venture map in 2026 — Shipt’s $550M Target exit, Acclinate and ArcheHealth raises, UAB spinouts, and the local funds that write first checks.
-
Baltimore Startups and VC Firms in 2026: TEDCO, Hopkins Clinical AI, Pearl Diagnostics
Baltimore venture map in 2026 — TEDCO, Latimer, TCP, Maryland Momentum, plus kweliTV, Bayesian Health, Pearl Diagnostics, Inner Logic, and Neurava.
-
W Health Ventures Fund II: ~$80M Final Close at ₹700 Cr for Company Creation
W Health Ventures closed Fund II at ₹700 crore (~$80M), above its ₹630 Cr target — a physician-operator company-creation vehicle already launching Everhope Oncology and Everbright Health.
-
Ultrahuman’s $70M at $365M: Smart Rings Become On-Finger Computers
Qualcomm Ventures joined Ultrahuman’s $70M round ($65M equity + $5M debt) at a $365M valuation — betting rings can run software, AI, and games on-device, not only sleep metrics.
-
Thyme Care’s $125M Series E: Oncology Navigation Clears $2B With Payer Capital
Morgan Health led Thyme Care’s $125M+ Series E above a $2B valuation — Humana, CVS Health Ventures, AlleyCorp, and a16z Bio + Health joined as the company spins up Thyme Companies for biosimilars and trial access.
-
Star51 Capital's Medtech Fund: Abbott and Mayo Clinic Anchor a New Model
Star51 Capital announced the first close of its medtech fund in June 2026, led by Abbott and Mayo Clinic — a strategic-anchored vehicle bridging innovation and acquisition.
-
Semble's £30M Series C: Modern Software for Healthcare Providers
UK healthcare-tech company Semble raised a £30M Series C led by Revaia in June 2026, scaling its practice-management platform for clinicians.
-
QuantHealth’s $45M Series B: Simulate the Trial Before You Enroll Patients
Qumra Capital led QuantHealth’s $45M Series B for AI clinical-trial simulation — predicting trial outcomes before first patient in, with Sanofi Ventures returning.
-
Parallel's €17M Series A: Paris Healthtech Doubles Down on Coding Agents
Parallel's Paris round highlights Europe's growing confidence in vertical AI agents for regulated industries like healthcare.
-
Ona Therapeutics's $86.6M Series B: Barcelona's ADC Cancer Bet
Barcelona biopharma Ona Therapeutics closed an oversubscribed $86.6M Series B in June 2026 to advance first-in-class antibody-drug conjugates for resistant cancers.
-
Onos Health’s $17M Series A: Behavioral Health AI for Health Plans
Costanoa led Onos Health’s $17M Series A with Flare Capital and CVS Health Ventures — Aetna already live. The product parses unstructured behavioral-health notes that legacy utilization tools miss.